High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites

J Hepatol. 2004 Mar;40(3):424-30. doi: 10.1016/j.jhep.2003.11.017.

Abstract

Background/aims: Hypersensitivity to endotoxin is a recognized feature in cirrhosis. High-density lipoproteins (HDL) have a high capacity to inactivate endotoxin. The aim was to determine if HDL reduces the effect of endotoxin on cytokine production and systemic hemodynamics in experimental cirrhosis.

Methods: The study was performed in control and rats with carbon-tetrachloride induced cirrhosis with ascites. Hemodynamic parameters were determined before and after several doses of endotoxin. The effects of 25 microg/kg of endotoxin on the serum concentration of TNFalpha and mean arterial pressure (MAP) were determined after treatment with HDL (80 mg/kg) or saline.

Results: Whereas endotoxin decreased MAP only at doses of 100 and 1000 microg/kg in control rats, in cirrhotic rats significant hypotension occurred at doses of 25, 50, 100 and 1000 microg/kg. Following the administration of endotoxin (25 microg/kg) the serum levels of TNFalpha were 140 times higher in cirrhotic than in control rats (89?835+/-21?090 vs. 625+/-137 pg/ml; P<0.001). Serum TNFalpha was 80% lower in cirrhotic rats pretreated with HDL (18?890+/-5012 pg/ml; P<0.001) than in those pretreated with saline. The administration of endotoxin (25 microg/kg) was associated with a significant lower decrease of MAP in cirrhotic rats pretreated with HDL than in those receiving saline (11.9+/-3.5 vs. 24.7+/-4.3%; P<0.05).

Conclusions: HDL attenuates the increased effect of endotoxin on cytokine production and systemic hemodynamic in cirrhosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascites / etiology
  • Blood Pressure / drug effects
  • Carbon Tetrachloride
  • Cytokines / biosynthesis*
  • Endotoxins / antagonists & inhibitors*
  • Hemodynamics / drug effects*
  • Injections, Intravenous
  • Lipopolysaccharides / administration & dosage
  • Lipoproteins, HDL / administration & dosage
  • Lipoproteins, HDL / pharmacology*
  • Liver Cirrhosis, Experimental / chemically induced
  • Liver Cirrhosis, Experimental / complications
  • Liver Cirrhosis, Experimental / metabolism
  • Liver Cirrhosis, Experimental / physiopathology*
  • Male
  • Rats
  • Rats, Wistar
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Cytokines
  • Endotoxins
  • Lipopolysaccharides
  • Lipoproteins, HDL
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Carbon Tetrachloride